Alnylam Pharmaceuticals (ALNY) PT Lowered to $300 at Morgan Stanley
Morgan Stanley analyst Andrew Galler ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
